DJ, I., DR, S., EA, K., N, H., LS, S., R, C., & V, C. (2008). The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clinical therapeutics, 30(2), 341. https://doi.org/10.1016/j.clinthera.2008.02.003
Chicago Style (17th ed.) CitationDJ, Isaacman, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, and Ciuryla V. "The Impact of Indirect (herd) Protection on the Cost-effectiveness of Pneumococcal Conjugate Vaccine." Clinical Therapeutics 30, no. 2 (2008): 341. https://doi.org/10.1016/j.clinthera.2008.02.003.
MLA (9th ed.) CitationDJ, Isaacman, et al. "The Impact of Indirect (herd) Protection on the Cost-effectiveness of Pneumococcal Conjugate Vaccine." Clinical Therapeutics, vol. 30, no. 2, 2008, p. 341, https://doi.org/10.1016/j.clinthera.2008.02.003.